A decrease of plasma macrophage migration inhibitory factor concentration is associated with lower numbers of...

Area of Science:

• Immunology
• Infectious Diseases
• Malariology

Background:

• Macrophage migration inhibitory factor (MIF) is implicated in malarial anemia pathogenesis.
• Previous field studies show conflicting results on circulating MIF levels in Plasmodium falciparum malaria.

Purpose of the Study:

• To investigate plasma MIF levels over time during experimental Plasmodium falciparum infection in healthy volunteers.
• To correlate MIF changes with immune cell populations and cytokine profiles.

Main Methods:

• Experimental Plasmodium falciparum infection in 10 healthy volunteers.
• Longitudinal measurement of plasma MIF, lymphocyte counts, monocyte/macrophage counts, IL-10, IL-8, and IL-1beta.
• Controlled study conditions.

Main Results:

• Plasma MIF levels significantly decreased during early blood-stage infection, reaching a nadir at day 8 post-infection.
• A concurrent decrease in circulating lymphocytes, a key MIF source, was observed.
• Monocyte/macrophage counts were unchanged; IL-10 was low, and pro-inflammatory cytokines (IL-8, IL-1beta) were only marginally elevated at MIF nadir.

Conclusions:

• Circulating MIF levels decrease early in blood-stage malaria.
• This reduction is primarily attributed to a decline in circulating lymphocytes.
• The findings help reconcile conflicting reports on MIF in malaria pathogenesis.